HeartSciences Inc.
HSCSNasdaq
$2.69
↓ -1.8%Jul 17 close · end-of-day
Price
1Y↓ -31.9%
End-of-day closes; the latest point is the live 15-min-delayed price · split & dividend adjusted · chart by TradingView
Key statistics
Market Cap
—
Enterprise Value
—
P/E
—
P/S
—
P/B
—
EV/EBITDA
—
PEG
—
FCF Yield
—
Dividend Yield
—
Revenue (TTM)
—
Net Income (TTM)
-$8.5M
Free Cash Flow (TTM)
—
Gross Margin
—
Operating Margin
—
Net Margin
—
ROE
-319.9%
ROIC
—
Debt / Equity
—
Net Cash
$3.4M
Return 1Y
-35.3%
Company profile
We are a medical technology company focused on applying innovative AI-based technology to an ECG (also known as an EKG) to expand and improve an ECG’s clinical usefulness. We are a Texas corporation based in Southlake, Texas and were incorporated in Texas in August 2007. Our principal executive offices are located at 550 Reserve Street, Suite 360, Southlake TX.
- CEO
- Andrew C. Simpson
- Sector
- Manufacturing
- Industry
- Medical Equipment
- Employees
- 10
- Headquarters
- Texas
- Website
- heartsciences.com
Management & directors
- Simpson AndrewSee Remarks
- Hilz Mark TCOO, Secretary and Director
Roles derived from SEC Form 4 filings.
Earnings
HSCS Q3 2026 Earnings
Period ends 2026-01-31
MetricActualYoY
Revenue$0.00—
Diluted EPS——
Actuals from SEC filings; YoY vs the year-ago quarter. Analyst estimates & surprise require a data feed (coming soon).
Financial statements
| Line item | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|
| Revenue | $14,373.00 | $5,150.00 | $18,600.00 | $4,350.00 |
| Gross profit | $6,483.00 | $2,354.00 | $12,519.00 | $2,470.00 |
| Operating income | -$4.7M | -$6.1M | -$6.3M | -$8.4M |
| Net income | -$4.8M | -$6.4M | -$6.6M | -$8.8M |
| Diluted EPS | -$1.45 | -$80.00 | -$18.74 | -$9.34 |
| Operating cash flow | -$3.6M | -$5.8M | -$6.1M | -$7.4M |
| Free cash flow | -$3.6M | -$5.8M | -$6.1M | -$7.4M |
| Gross margin | 45.1% | 45.7% | 67.3% | 56.8% |
| Operating margin | -32765.6% | -118698.3% | -33902.0% | -192013.1% |
| Net margin | -33592.6% | -123384.3% | -35511.9% | -201499.5% |
| Line item | Q4 '24 | Q1 '24 | Q2 '24 | Q3 '25 | Q4 '25 | Q1 '25 | Q2 '25 | Q3 '26 |
|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | — | $0.00 | — | $1,900.00 | $2,419.00 | $0.00 |
| Gross profit | — | — | — | $0.00 | — | $1,140.00 | $1,411.00 | $0.00 |
| Operating income | -$1.9M | -$2.1M | -$2.0M | -$2.4M | -$1.9M | -$1.9M | -$2.1M | -$1.9M |
| Net income | -$1.8M | -$2.1M | -$2.1M | -$2.5M | -$2.1M | -$2.1M | -$2.4M | -$2.0M |
| Diluted EPS | $13.42 | -$2.64 | -$2.27 | -$2.57 | -$1.86 | -$1.58 | -$0.85 | — |
| Operating cash flow | -$1.6M | -$2.0M | -$2.2M | -$1.6M | -$1.6M | -$2.0M | -$2.3M | -$1.5M |
| Free cash flow | -$1.6M | — | — | -$1.6M | — | — | — | -$1.5M |
| Gross margin | — | — | — | — | — | 60.0% | 58.3% | — |
| Operating margin | — | — | — | — | — | -98637.8% | -85713.2% | — |
| Net margin | — | — | — | — | — | -108157.6% | -97179.4% | — |
Company news
Jun 23, 2026
Analyst estimates
Coming soonConsensus revenue & EPS estimates and price targets will appear here once a forward-estimates data feed is connected.
Insider transactions
No insider transactions in the last 12 months.
| Date | Insider | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|
| 2026-06-22 | Simpson Andrew· See Remarks | Award | 425,000 | — | — | filing |
| 2025-11-28 | Simpson Andrew· See Remarks | Award | 70,000 | — | — | filing |
| 2025-07-29 | HILZ MARK T· COO, Secretary and Director | Sale | 4,416 | $3.54 | $15,621.16 | filing |
Latest 3 transactions.
Fundamentals & filings from SEC EDGAR. Prices adjusted for splits & dividends. Not investment advice.